MTOR and metastatic neoplasm: Limited-stage disease treatment mainly consists of surgery, while for advanced and metastatic disease, somatostatin analogs, mTOR inhibitors, PRRT, and cytotoxic chemotherapy control symptoms and provide a limited survival benefit.